First FDA Approved Potassium Phosphates Injection Expected to Address Previous Market Shortages and Provide Improved Safety Profile as Opposed to Using Unapproved Products FARMVILLE N.C., March 17, 2020 /PRNewswire/ —…
Read More
Uncategorized
First Ever FDA Approved Potassium Phosphates Injection Expected to Address Previous Market Shortages and Provide Improved Safety Profile as Opposed to Using Unapproved Products Farmville NC, February 27, 2020 —…
Farmville, NC. October 30, 2017 – CMP Pharma today announced that CaroSpir® (Spironolactone Oral Suspension, 25 mg/5 mL), the first and only FDA-approved oral liquid dosage form of the potassium-sparing…
Farmville, NC. August 7, 2017 – CMP Pharma today announced that the US Food and Drug Administration (FDA) has granted final approval of the company’s New Drug Application (NDA) for CaroSpir® (Spironolactone Oral…
Farmville, NC – February 5, 2016 – CMP Pharma, Inc. of Farmville, NC and Generic Specialty Pharma Ltd. (GSP) of Dublin, Ireland have reached an agreement to partner on the…
Farmville, NC – March 5, 2015 – CMP Pharma, Inc. has licensed the marketing and distribution rights for Trianex® to Promius Pharma, LLC. Trianex ® a mid-potency corticosteroid, is notable…
Carolina Medical Products, Inc. (CMP) has officially changed its name to CMP Pharma. This new name more appropriately reflects the nature of its current business as a specialty pharmaceutical company…
CMP Pharma (formerly Carolina Medical Products Co.) and Kiel Laboratories have signed an agreement to develop, seek regulatory approval, and commercialize two new prescription drugs. The first drugs will be…